Clinical Study
Inflammatory Mediators in Induced Sputum and Airway Hyperresponsiveness in Cough Variant Asthma during Long-Term Inhaled Corticosteroid Treatment
Table 1
Clinical characteristics of the three studied groups.
| | CVA group () | Asthma group () | Control group () |
| Sex (M : F) | 28 (13 : 15) | 23 (10 : 13) | 22 (12 : 10) | Age (years) | 42.96 ± 14.23 | 40.73 ± 11.41 | 38.76 ± 13.18 | Total IgE (IU·mL-1) | 657.85 (24.00 ~ 2342.00)a | 593.74 (37.40 ~ 2592.00)a | 65.46 (17.34 ~ 153.00) | FEV1% predicted | 93.76 ± 12.72 | 90.24 ± 15.11 | 102.12 ± 14.49 | FEV1/FVC | 82.67 ± 4.76 | 84.13 ± 6.92 | 89.21 ± 4.7 | Leukocyte (109/L) | 6.65 ± 1.78 | 7.06 ± 1.91 | 6.71 ± 1.72 | Neutrophil (%) | 56.85 ± 9.52 | 60.72 ± 9.47 | 57.39 ± 7.20 | Eosinophil (%) | 7.28 ± 2.46a | 6.86 ± 2.58a | 3.08 ± 1.91 | Basophil (%) | 0.092 ± 0.076 | 0.074 ± 0.062 | 0.088 ± 0.049 | Monocytes (%) | 6.29 ± 1.05 | 6.47 ± 1.90 | 6.51 ± 1.35 | Lymphocytes (%) | 29.55 ± 8.83 | 33.16 ± 14.27 | 27.86 ± 15.23 | Atopy | 12/16 a | 10/13a | 0/22 |
|
|
compared with controls.
|